D.P. Doogan

1.0k total citations
14 papers, 765 citations indexed

About

D.P. Doogan is a scholar working on Pharmacology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, D.P. Doogan has authored 14 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 9 papers in Psychiatry and Mental health and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in D.P. Doogan's work include Treatment of Major Depression (9 papers), Electroconvulsive Therapy Studies (4 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers). D.P. Doogan is often cited by papers focused on Treatment of Major Depression (9 papers), Electroconvulsive Therapy Studies (4 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers). D.P. Doogan collaborates with scholars based in United Kingdom, Netherlands and United States. D.P. Doogan's co-authors include Vincent Caillard, Alec Coppen, H. M. van Praag, Stuart Montgomery, K. Wood, C. A. L. Moon, Peter O. Behan and Paul M. Thompson and has published in prestigious journals such as Clinical Infectious Diseases, The British Journal of Psychiatry and Journal of Affective Disorders.

In The Last Decade

D.P. Doogan

14 papers receiving 690 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D.P. Doogan United Kingdom	11	478	399	177	158	103	14	765
Vincent Caillard France	11	332 0.7×	436 1.1×	139 0.8×	201 1.3×	87 0.8×	20	806
M. Stabl Switzerland	16	430 0.9×	398 1.0×	170 1.0×	101 0.6×	80 0.8×	23	679
N Reisby Denmark	14	520 1.1×	483 1.2×	296 1.7×	190 1.2×	102 1.0×	27	1.1k
D. Montgomery United Kingdom	16	383 0.8×	366 0.9×	156 0.9×	130 0.8×	136 1.3×	33	731
Frederick Quitkin United States	7	702 1.5×	509 1.3×	223 1.3×	182 1.2×	236 2.3×	8	1.1k
A.R. Entsuah Canada	7	703 1.5×	388 1.0×	347 2.0×	189 1.2×	175 1.7×	12	983
Robert E. McCue United States	17	475 1.0×	449 1.1×	154 0.9×	57 0.4×	127 1.2×	32	840
C.M.E. Kremer United States	13	651 1.4×	569 1.4×	179 1.0×	221 1.4×	158 1.5×	34	1.2k
J O Cole United States	8	350 0.7×	353 0.9×	147 0.8×	89 0.6×	57 0.6×	10	583
Sharyn R. Batey United States	13	641 1.3×	709 1.8×	347 2.0×	88 0.6×	122 1.2×	26	1.2k

Countries citing papers authored by D.P. Doogan

Since Specialization

Citations

This map shows the geographic impact of D.P. Doogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.P. Doogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.P. Doogan more than expected).

Fields of papers citing papers by D.P. Doogan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.P. Doogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.P. Doogan. The network helps show where D.P. Doogan may publish in the future.

Co-authorship network of co-authors of D.P. Doogan

This figure shows the co-authorship network connecting the top 25 collaborators of D.P. Doogan. A scholar is included among the top collaborators of D.P. Doogan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.P. Doogan. D.P. Doogan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Doogan, D.P., et al.. (1994). A double-blind, placebo-controlled comparison of sertraline and dothiepin in the treatment of major depression in general practice. International Clinical Psychopharmacology. 9(2). 95–100. 52 indexed citations

Moon, C. A. L., et al.. (1994). A double-blind comparison of sertraline and clomipramine in the treatment of major depressive disorder and associated anxiety in general practice. Journal of Psychopharmacology. 8(3). 171–176. 32 indexed citations

Behan, Peter O., et al.. (1994). A Pilot Study of Sertraline for the Treatment of Chronic Fatigue Syndrome. Clinical Infectious Diseases. 18(Supplement_1). S111–S111. 14 indexed citations

Doogan, D.P. & Vincent Caillard. (1992). Sertraline in the Prevention of Depression. The British Journal of Psychiatry. 160(2). 217–222. 188 indexed citations

Thompson, Paul M., et al.. (1992). SERTRALINE IN THE TREATMENT OF DEPRESSION IN PRIMARY CARE. Clinical Neuropharmacology. 15. 83B–83B. 2 indexed citations

Doogan, D.P.. (1991). Toleration and Safety of Sertraline. International Clinical Psychopharmacology. 6. 47–47. 46 indexed citations

Montgomery, Stuart, et al.. (1991). The Influence of Different Relapse Criteria on the Assessment of Long-Term Efficacy of Sertraline. International Clinical Psychopharmacology. 6. 37–46. 35 indexed citations

Coppen, Alec & D.P. Doogan. (1988). Serotonin and its place in the pathogenesis of depression.. PubMed. 49 Suppl. 4–11. 82 indexed citations

Doogan, D.P. & Vincent Caillard. (1988). Sertraline: a new antidepressant.. PubMed. 49 Suppl. 46–51. 105 indexed citations

10.

Doogan, D.P.. (1983). Prophylaxis of migraine with beta-blockers.. PubMed. 227(1377). 441–4. 2 indexed citations

11.

Doogan, D.P., et al.. (1982). Fluvoxamine and chlorimipramine in endogenous depression. Journal of Affective Disorders. 4(3). 249–259. 63 indexed citations

12.

Doogan, D.P., et al.. (1982). A placebo controlled study of the cardiovascular effects of fluvoxamine and clovoxamine in human volunteers.. British Journal of Clinical Pharmacology. 14(6). 805–808. 22 indexed citations

13.

Praag, H. M. van, et al.. (1981). Fluvoxamine and clomipramine in depressed patients A DOUBLE‐BLIND CLINICAL STUDY. Acta Psychiatrica Scandinavica. 64(1). 1–11. 112 indexed citations

14.

Doogan, D.P.. (1980). Fluvoxamine as an antidepressant drug. Neuropharmacology. 19(12). 1215–1216. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact